跳至主要内容
临床试验/EUCTR2016-002663-33-BE
EUCTR2016-002663-33-BE进行中(未招募)1 期

Preventing Oxidative stress induced Ischemic Injury and Systemic Inflammation complications during and after invasive Cardiac surgery with Alkaline Phosphatase (APPIRED III)

Alloksys Life Sciences BV0 个研究点目标入组 1,250 人开始时间: 2016年9月20日最近更新:
适应症

试验速览

阶段
1 期
状态
进行中(未招募)
入组人数
1,250

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

入选标准

  • A potential subject must meet all of the following criteria to participate in the study:
  • 1.> 21 years of age (legal adult in Singapore)
  • 2.Undergoing cardiac surgery with planned cardiopulmonary bypass
  • 3.Additive EuroSCORE II = 3
  • 4.Ability to provide informed consent (not incapacitated)
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range 625
  • F.1.3 Elderly (>=65 years) yes
  • F.1.3.1 Number of subjects for this age range 625

排除标准

  • Any subjects meeting the following criteria at baseline will be excluded:
  • 1.Already on renal replacement therapy
  • 2.Patients with chronic kidney disease defined as estimated glomerular filtration rate [eGFR] < 30 mL/min/1.73 m². [CKD stage > 3]
  • 3.Patients who are pregnant
  • 4.Concurrent enrolment in another clinical trial
  • 5.Known allergic reaction to bovine alkaline phosphatase or patient is vegetarian, vegan, or does not consume any bovine meat products (beef)
  • that is, the patient may not be tolerant for bovine proteins
  • 6. Patients with ongoing infections or current use of steroids

研究者

相似试验

进行中(未招募)
1 期
Preventing Systemic Inflammation after Cardiac surgery by Alkaline Phosphatase (APPIRED III)systemic inflammation as side-effect of heart-lung machine during cardiac surgeryMedDRA version: 20.0 Level: LLT Classification code 10017501 Term: Functional disturbances following cardiac surgery System Organ Class: 100000004863MedDRA version: 20.0 Level: LLT Classification code 10062357 Term: SIRS System Organ Class: 100000004867
EUCTR2016-002663-33-NLAlloksys Life Sciences BV1,250
进行中(未招募)
1 期
Preventing Systemic Inflammation after Cardiac surgery with Alkaline Phosphatase (APPIRED III)systemic inflammation as side-effect of heart-lung machine during cardiac surgeryMedDRA version: 20.0Level: LLTClassification code 10017501Term: Functional disturbances following cardiac surgerySystem Organ Class: 10022117 - Injury, poisoning and procedural complications
EUCTR2016-002663-33-ATAlloksys Life Sciences BV1,250
招募中
3 期
Preventing Oxidative stress-induced ischemic injury and systemic inflammation complications during and after invasive cardiac surgery with Alkaline Phosphatase (APPIRED III)renal failure
NL-OMON49105Alloksys Life Sciences BV150
进行中(未招募)
不适用
Prevention of atrial oxidative stress and electrical remodelling in patients undergoing cardiac surgery: randomised placebo-controlled trial of perioperative high-dose atorvastatin - Do statins prevent atrial rhythm disturbances after cardiac surgery?POST-OPERATIVE ATRIAL FIBRILLATIONMedDRA version: 13Level: SOCClassification code 10003658
EUCTR2009-013228-21-GBniversity of Oxford
已完成
2 期
The effect of zinc supplementation in chronic hemodialysis patientspatients with hemodialsis.Acute nephritic syndrome, Rapidly progressive nephritic syndrome, Chronic nephritic syndrome, Nephrotic syndrome, Unspecified nephritic syndrome, Glomerular disorders in diseases classified elsewhere, Acute renal failure, Chronic renal failure, UnspecifieN00, N01,N
IRCT138902033777N1Drug Applied Research Center-Tabriz University of Medical Sciences73